F Matthijssens
Overview
Explore the profile of F Matthijssens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia E, Veloso A, Oliveira M, Allen J, Loontiens S, Brunson D, et al.
Leukemia
. 2020 Jul;
35(3):679-690.
PMID: 32606318
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy of thymocytes and is largely driven by the NOTCH/MYC pathway. Yet, additional oncogenic drivers are required for transformation. Here, we identify...
2.
Peirs S, Frismantas V, Matthijssens F, Van Loocke W, Pieters T, Vandamme N, et al.
Leukemia
. 2017 Jan;
31(10):2037-2047.
PMID: 28074072
Inhibition of anti-apoptotic BCL-2 (B-cell lymphoma 2) has recently emerged as a promising new therapeutic strategy for the treatment of a variety of human cancers, including leukemia. Here, we used...
3.
Wallaert A, Durinck K, Van Loocke W, Van de Walle I, Matthijssens F, Volders P, et al.
Leukemia
. 2016 May;
30(9):1927-30.
PMID: 27168467
No abstract available.
4.
Lenaerts I, Braeckman B, Matthijssens F, Vanfleteren J
Anal Biochem
. 2002 Nov;
311(1):90-2.
PMID: 12441159
No abstract available.
5.
van Loo G, Saelens X, Matthijssens F, Schotte P, Beyaert R, Declercq W, et al.
Cell Death Differ
. 2002 Oct;
9(11):1207-11.
PMID: 12404119
Caspases are crucial for the initiation, propagation and execution of apoptosis. They normally exist as proenzymes, which can be activated through recruitment into activating complexes and by proteolytic cleavage by...